1. receiving any form of c1-inh therapy either acute or prophylactic treatment 2. history or suspicion of allergy to rabbits 3. neurological conditions related to injury 4. neuropathy related to diabetes 5. participants who are pregnant or lactating 6. largely incapacitated or bed ridden 7. currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study or have discontinued with 30 days of study entry from any other clinical study involving an investigational product 8. patients who, in the investigator's opinion, might not be suitable for the trial for safety reasons

1. receiving any form of c1-inh therapy either acute or prophylactic treatment 2. history or suspicion of allergy to rabbits 3. neurological conditions related to injury 4. neuropathy related to diabetes 5. participants who are pregnant or lactating 6. largely incapacitated or bed ridden 7. currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study or have discontinued with 30 days of study entry from any other clinical study involving an investigational product 8. patients who, in the investigator's opinion, might not be suitable for the trial for safety reasons

receiving any form of c1-inh therapy either acute or prophylactic treatment history or suspicion of allergy to rabbits neurological conditions related to injury neuropathy related to diabetes participants who are pregnant or lactating largely incapacitated or bed ridden currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study or have discontinued with 30 days of study entry from any other clinical study involving an investigational product patients who, in the investigator's opinion, might not be suitable for the trial for safety reasons

receiving any form of c1-inh therapy either acute or prophylactic treatment history or suspicion of allergy to rabbits neurological conditions related to injury neuropathy related to diabetes participants who are pregnant or lactating largely incapacitated or bed ridden currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study or have discontinued with 30 days of study entry from any other clinical study involving an investigational product patients who, in the investigator's opinion, might not be suitable for the trial for safety reasons

1. receiving any form of c1-inh therapy either acute or prophylactic treatment 2. history or suspicion of allergy to rabbits 3. neurological conditions related to injury 4. neuropathy related to diabetes 5. participants who are pregnant or lactating 6. largely incapacitated or bed ridden 7. currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study or have discontinued with 30 days of study entry from any other clinical study involving an investigational product 8. patients who, in the investigator's opinion, might not be suitable for the trial for safety reasons

1. receiving any form of c1-inh therapy either acute or prophylactic treatment 2. history or suspicion of allergy to rabbits 3. neurological conditions related to injury 4. neuropathy related to diabetes 5. participants who are pregnant or lactating 6. largely incapacitated or bed ridden 7. currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study or have discontinued with 30 days of study entry from any other clinical study involving an investigational product 8. patients who, in the investigator's opinion, might not be suitable for the trial for safety reasons